“…It has a wide range of physicochemical, mechanical, and thermal properties (Guan, Fujimoto, Sacks, & Wagner, ; Kucinska‐Lipka, Gubanska, Janik, & Sienkiewicz, ). To increase cytocompatibility and hemocompatibility, we have previously developed of the surface modified PU nanofibers with VEGF and heparin (Davoudi et al, ), PU/silica composites (Rashti et al, ), POMS/PU nanocomposites (Yahyaei, Mohseni, & Ghanbari, ), and the new polyurethane modified with biomacromolecules (Asadpour, Yeganeh, Ai, & Ghanbari, ), ferulic acid (Asadpour et al, ) and PCL (Asadpour et al, ) for cardiovascular applications.…”